BIIB vs LCUT · P/E 21, rev $9.89B vs rev $285.1M
Biogen Inc (BIIB) versus Lifetime Brands Inc (LCUT) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Lifetime Brands Inc (LCUT) is a furnishings, fixtures & appliances company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported LCUT revenue for 2026-06-30 was $285.1M. Net income was $14.8M. Revenue was up 98.6% from 2026-03-31 to 2026-06-30. LCUT currently screens at market cap $97.5M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. LCUT currently screens at market cap $97.5M.
Not investment advice. Open the BIIB and LCUT stock pages for the full models.
Not investment advice.